0	15	Transcriptional	transcriptional	JJ
16	26	regulation	regulation	NN
27	33	during	during	IN
34	46	myelopoiesis	myelopoiesis	NN
46	47	.	.	.

49	52	The	the	DT
53	64	coordinated	coordinate	VBN
65	75	production	production	NN
76	78	of	of	IN
79	82	all	all	DT
83	88	blood	blood	NN
89	94	cells	cell	NNS
95	99	from	from	IN
100	101	a	a	DT
102	108	common	common	JJ
109	113	stem	stem	NN
114	118	cell	cell	NN
119	121	is	be	VBZ
122	123	a	a	DT
124	130	highly	highly	RB
131	140	regulated	regulate	VBN
141	148	process	process	NN
149	158	involving	involve	VBG
159	169	successive	successive	JJ
170	176	stages	stage	NNS
177	179	of	of	IN
180	190	commitment	commitment	NN
191	194	and	and	CC
195	210	differentiation	differentiation	NN
210	211	.	.	.

212	216	From	from	IN
217	225	analyses	analysis	NNS
226	228	of	of	IN
229	233	mice	mouse	NNS
234	243	deficient	deficient	JJ
244	246	in	in	IN
247	260	transcription	transcription	NN
261	267	factor	factor	NN
268	273	genes	gene	NNS
274	277	and	and	CC
278	282	from	from	IN
283	286	the	the	DT
287	304	characterizations	characterization	NNS
305	307	of	of	IN
308	318	chromosome	chromosome	NN
319	330	breakpoints	breakpoint	NNS
331	333	in	in	IN
334	339	human	human	JJ
340	349	leukemias	leukemia	NNS
349	350	,	,	,
351	353	it	it	PRP
354	357	has	have	VBZ
358	364	become	become	VBN
365	372	evident	evident	JJ
373	377	that	that	IN
378	391	transcription	transcription	NN
392	399	factors	factor	NNS
400	403	are	be	VBP
404	413	important	important	JJ
414	424	regulators	regulator	NNS
425	427	of	of	IN
428	441	hematopoiesis	hematopoiesis	NN
441	442	.	.	.

443	449	During	during	IN
450	462	myelopoiesis	myelopoiesis	NN
462	463	,	,	,
464	469	which	which	WDT
470	478	includes	include	VBZ
479	482	the	the	DT
483	494	development	development	NN
495	497	of	of	IN
498	510	granulocytic	granulocytic	JJ
511	514	and	and	CC
515	524	monocytic	monocytic	JJ
525	533	lineages	lineage	NNS
533	534	,	,	,
535	548	transcription	transcription	NN
549	556	factors	factor	NNS
557	561	from	from	IN
562	569	several	several	JJ
570	578	families	family	NNS
579	582	are	be	VBP
583	589	active	active	JJ
589	590	,	,	,
591	600	including	include	VBG
601	609	AML1/CBF	AML1/CBF	NNP
610	614	beta	beta	NN
614	615	,	,	,
616	621	C/EBP	C/EBP	NNP
621	622	,	,	,
623	626	Ets	Ets	NNP
626	627	,	,	,
628	633	c-Myb	c-myb	NN
633	634	,	,	,
635	638	HOX	HOX	NNP
638	639	,	,	,
640	643	and	and	CC
644	649	MZF-1	MZF-1	NNP
649	650	.	.	.

651	654	Few	few	JJ
655	657	of	of	IN
658	663	these	these	DT
664	671	factors	factor	NNS
672	675	are	be	VBP
676	685	expressed	express	VBN
686	697	exclusively	exclusively	RB
698	700	in	in	IN
701	708	myeloid	myeloid	JJ
709	714	cells	cell	NNS
714	715	;	;	:
716	723	instead	instead	RB
724	726	it	it	PRP
727	734	appears	appear	VBZ
735	739	that	that	IN
740	744	they	they	PRP
745	758	cooperatively	cooperatively	RB
759	767	regulate	regulate	VBP
768	781	transcription	transcription	NN
782	784	of	of	IN
785	801	myeloid-specific	myeloid-specific	JJ
802	807	genes	gene	NNS
807	808	.	.	.

809	813	Here	here	RB
814	816	we	we	PRP
817	824	discuss	discuss	VBP
825	831	recent	recent	JJ
832	840	advances	advance	NNS
841	843	in	in	IN
844	859	transcriptional	transcriptional	JJ
860	870	regulation	regulation	NN
871	877	during	during	IN
878	890	myelopoiesis	myelopoiesis	NN
890	891	.	.	.